Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

David R Baldwin¹, S W Duffy², A Devaraj, J K Field^{3

4}

Affiliations

¹ Respiratory Medicine Unit, Nottingham University Hospitals and Honorary Professor, University of Nottingham, David Evans Centre, Nottingham City Hospital Campus, Nottingham, UK.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ Royal Brompton and Harefield NHS Foundation Trust and Honorary Senior Lecturer, Imperial College, London, UK.
⁴ Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Institute of Translational Medicine, Liverpool, UK.

Editorial

David R Baldwin et al. Thorax. 2017 Jan.

. 2017 Jan;72(1):6-7.

doi: 10.1136/thoraxjnl-2016-209011. Epub 2016 Oct 21.

David R Baldwin¹, S W Duffy², A Devaraj, J K Field^{3

4}

¹ Respiratory Medicine Unit, Nottingham University Hospitals and Honorary Professor, University of Nottingham, David Evans Centre, Nottingham City Hospital Campus, Nottingham, UK.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ Royal Brompton and Harefield NHS Foundation Trust and Honorary Senior Lecturer, Imperial College, London, UK.
⁴ Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Institute of Translational Medicine, Liverpool, UK.

No abstract available

Keywords: Imaging/CT MRI etc; Lung Cancer.

Comment on

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H. Yousaf-Khan U, et al. Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30. Thorax. 2017. PMID: 27364640 Clinical Trial.